Qube Research & Technologies LTD Atri Cure, Inc. Put Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ATRC
# of Institutions
209Shares Held
48.6MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$173 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$173 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$157 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$100 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$74.8 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.74B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...